Upregulation of Functional β 3 -Adrenergic Receptor in the Failing Canine Myocardium
- 28 September 2001
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 89 (7), 599-606
- https://doi.org/10.1161/hh1901.098042
Abstract
Abstract— Altered expression and functional responses to cardiac β3-adrenergic receptors (ARs) may contribute to progressive cardiac dysfunction in heart failure (CHF). We compared myocyte β3-AR mRNA and protein levels and myocyte contractile, [Ca2+]i transient, and Ca2+ current (ICa,L) responses to BRL-37344 (BRL, 10−8 mol/L), a selective β3-AR agonist, in 9 instrumented dogs before and after pacing-induced CHF. Myocytes were isolated from left ventricular myocardium biopsy tissues. Using reverse transcription–polymerase chain reaction, we detected β3-AR mRNA from myocyte total RNA in each animal. Using a cloned canine β3-AR cDNA probe and myocyte poly A+ RNA, we detected a single band about 3.4 kb in normal and CHF myocytes. β3-AR protein was detected by Western blot. β3-AR mRNA and protein levels were significantly greater in CHF myocytes than in normal myocytes. Importantly, these changes were associated with enhanced β3-AR–mediated negative modulation on myocyte contractile response and [Ca2+]i regulation. Compared with normal myocytes, CHF myocytes had much greater decreases in the velocity of shortening and relengthening with BRL accompanied by larger reductions in the peak systolic [Ca2+]i transient and ICa,L. These responses were not modified by pretreating myocytes with metoprolol (a β1-AR antagonist) or nadolol (a β1- and β2-AR antagonist), but were nearly prevented by bupranolol or L-748,337 (β3-AR antagonists). We conclude that in dogs with pacing-induced CHF, β3-AR gene expression and protein levels are upregulated, and the functional response to β3-AR stimulation is increased. This may contribute to progression of cardiac dysfunction in CHF.Keywords
This publication has 16 references indexed in Scilit:
- Cardiac function and heart failureJournal of the American College of Cardiology, 2001
- β3-adrenoceptor deficiency blocks nitric oxide–dependent inhibition of myocardial contractilityJCI Insight, 2000
- The Negative Inotropic Effect of β3-Adrenoceptor Stimulation in the Beating Guinea Pig HeartJournal of Cardiovascular Pharmacology, 2000
- The β3-Adrenergic Receptor Activates Mitogen-activated Protein Kinase in Adipocytes through a Gi-dependent MechanismJournal of Biological Chemistry, 1999
- β-ADRENERGIC RECEPTORS AND RECEPTOR SIGNALING IN HEART FAILUREAnnual Review of Pharmacology and Toxicology, 1999
- The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.JCI Insight, 1998
- Functional beta3-adrenoceptor in the human heart.JCI Insight, 1996
- Cellular and molecular alterations in the adrenergic system with cardiomyopathy induced by tachycardiaCardiovascular Research, 1994
- Tissue distribution of beta 3-adrenergic receptor mRNA in man.JCI Insight, 1993
- Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugsNature, 1984